Aug. 19, 2011, 9:31 a.m. EDT

SHANGRI-LA COUNTY, China, Aug. 19, 2011 /PRNewswire via COMTEX/ -- Tibet Pharmaceuticals, Inc., an emerging specialty pharmaceutical company engaged in the development, manufacturing and marketing of traditional Tibetan medicine in China, today announced the availability of the transcript for its second quarter 2011 earnings conference call, held on August 16th.

During the conference call Sally He, Tibet Pharmaceutical's VP and Assistant to the Chairman, stated, "As evidenced by our numbers this year, Tibet Pharmaceuticals has positioned itself to take full advantage of the favorable market conditions in China."

Summary of Second Quarter 2011 Financial Results:

Revenue of $8.7 million, an increase of 12% from $7.8 million in Q2 2010

Net income of $3.5 million compared to $3.4 million in Q2 2010

Fully diluted EPS of $0.25

Ms. He continued, "As we move into the third quarter of 2011, we expect to further increase awareness of our top selling traditional Tibetan medicines, with a particular focus on organic growth and accretive acquisitions."

Throughout the conference call Tibet's management talked about the company's portfolio of traditional Tibetan medicine products, its operations and production capacity and full details surrounding its revenue and earnings numbers for the second quarter ended June 30, 2011 and the first half of fiscal 2011.